logo

Health Care News

Share

Verrica Gets CRL From FDA For VP-102 NDA For The Treatment Of Molluscum Contagiosum

UniQure Says FDA Accepts BLA For Etranacogene Dezaparvovec Under Priority Review

Merck: European Commission Approves KEYTRUDA Plus Chemotherapy In Breast Cancer

Roivant Sciences: FDA Approves Dermavant's VTAMA Cream, 1% For Plaque Psoriasis In Adults

SpringWorks Therapeutics Says Nirogacestat Meets Endpoints In Phase 3 DeFi Trial

Hikma Pharma: Siggi Olafsson Resigns As CEO

Innoviva To Acquire Entasis Therapeutics For $2.20/Shr Cash

Ocugen Says FDA Lifts Clinical Hold On Company's Phase 2/3 Clinical Trial, OCU-002, For COVAXIN

Merck KGaA To Invest EUR 440 Mln In Two Major Life Science Projects In Ireland Over Five Years

AstraZeneca's Covid-19 Vaccine Vaxzevria Gets EU Approval As Third Dose Booster